EU Cites ‘Constructive’ Talks With Gilead Over Virus Drug

(Bloomberg) -- European Union officials held talks with Gilead Sciences Inc. executives on Monday in a bid to hammer out a deal to secure its antiviral drug remdesivir to combat the coronavirus.
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.